IDiyas

For the Inventor, By the Inventor

Doylestown, PA, United States of America

David M Fink

USPTO Granted Patents = 18 

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Doylestown, PA (US) (1990 - 1994)
  • Lebanon, NJ (US) (1997 - 1999)

Company Filing History:

goldMedal13 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal4 out of 236 
 
Hoechst Marion Roussel
 patents
where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...
18 patents (USPTO):
1. 12263022 - Medical waste grinding and separation system with pathogen neutralization (2025-04-01),
2. 6004977 - N-(pyridinylamino) isoindolines and related compounds (1999-12-21),
3. 5948798 - Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles (1999-09-07),
4. 5728717 - Pyridiniminyl-1,2-benzisothiazoles (1998-03-17),
5. 5668154 - Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles (1997-09-16),
6. 5340936 - 8-azabicyclo[3.2.1]octane methanone and corresponding oximes (1994-08-23),
7. 5334599 - Heteroaryl-8-azabicyclo[3,2,1]octanes as antipsychotic agents, (1994-08-02),
8. 5310914 - Process of preparing 5-amino-5,6,7,8-tetrahydroquinolines and related (1994-05-10),
9. 5264575 - Process of preparing 2,6-methano-1,3-benzodiazocine compounds (1993-11-23),
10. 5234931 - Heteroaryl-8-azabicyclo[3.2.1]octanes as antipsychotic agents, (1993-08-10),
11. 5216164 - 5-amino-5,6,7,8-tetrahydroquinolines and related compounds (1993-06-01),
12. 5204480 - 5-(1-hydroxylcycloalkyl)-2-methoxy pyridine compounds (1993-04-20),
13. 5112981 - 5-(1-aminocyclohexyl)-2(1H)-pyridinone and related compounds (1992-05-12),
14. 5110815 - 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and (1992-05-05),
15. 5097033 - 2,6-methano-1,3-benzodiazocine compounds (1992-03-17),

Title: The Innovative Contributions of David M. Fink

Introduction

David M. Fink is a notable inventor based in Doylestown, PA, with a remarkable portfolio of 18 patents. His work primarily focuses on advancements in medical technology and pharmaceuticals, showcasing his commitment to improving healthcare solutions.

Latest Patents

Among his latest innovations is a medical waste grinding and separation system with pathogen neutralization. This system is designed to safely neutralize and dispose of medical sharps, such as syringes. It features an outer casing, a sharps aperture, a grinding head, and a rotary grinding tool motor, all working together to ensure safe disposal. Another significant patent involves novel N-(pyridinylamino) isoindolines and related compounds. This invention presents intermediates and processes for preparing these compounds, which are aimed at relieving memory dysfunction and treating depression.

Career Highlights

David has had a distinguished career, having worked with prominent companies such as Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. His experience in these organizations has contributed significantly to his expertise in the pharmaceutical field.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Richard C. Effland and Barbara E. Kurys. These partnerships have likely enriched his work and led to innovative solutions in his field.

Conclusion

David M. Fink's contributions to medical technology and pharmaceuticals through his patents reflect his dedication to innovation and improving healthcare. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…